A new federal bill aims to reduce the number of people dying from opioids and other prescription painkillers.
It’s called the American Recovery and Reinvestment Act.
It would require the Food and Drug Administration to set a cap on the number and type of drugs that can be prescribed for people with chronic pain.
It would also allow the Food & Drug Administration (FDA) to limit the amount of opioid-related pain medication that can go into the marketplace.
It was approved by the Senate on Wednesday, and it’s expected to be approved by President Donald Trump’s administration.
The FDA, which regulates the opioid market, has not set a time limit for when it will consider whether to limit its approval of opioids, but experts have estimated that the FDA could limit the number or the amount that people can get a prescription for.
Currently, the FDA only approves new drugs that have a market value of $1 million or more.
The cap is currently $2 million.
Trump has called for the FDA to limit prescribing and dispensing of opioids and for its website to allow users to submit their prescriptions online.
He has said the new law would help reduce the opioid epidemic.
Critics have called the bill a Trojan horse for pharmaceutical companies.
A spokeswoman for the National Organization for the Reform of Marijuana Laws, which is supporting the bill, said the FDA would be making its decision about the bill “in consultation with the industry and the industry will be the first to know about it.”
“I think the FDA is moving in the wrong direction and has taken the drug companies out of the equation,” Amy Kreider said.
“I’m not saying that this bill is going to solve the opioid problem, but it’s certainly going to slow it down.”
According to the Centers for Disease Control and Prevention, more than 6 million Americans have used opioids in the past year.
About 20% of Americans over age 50 are taking opioids for pain, and some people take them for years to manage chronic pain, which can make them more susceptible to overdose.
The CDC estimates that about 10 million Americans, or roughly 3% of the population, are using opioids for chronic pain each day.
The bill also would limit the marketing of prescription opioid painkillers, according to the Associated Press.
People who have chronic pain can be treated for chronic conditions that include arthritis, cancer, spinal cord injuries, and epilepsy.
The bill would also make it easier for people to access prescription pain medications if they have a serious medical condition.
The Associated Press contributed to this report.